BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34822024)

  • 1. Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review.
    Dhaliwal D; Shepherd TG
    Clin Exp Metastasis; 2022 Apr; 39(2):291-301. PubMed ID: 34822024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
    Terri M; Sandoval P; Bontempi G; Montaldo C; Tomero-Sanz H; de Turris V; Trionfetti F; Pascual-Antón L; Clares-Pedrero I; Battistelli C; Valente S; Zwergel C; Mai A; Rosanò L; Del Pozo MÁ; Sánchez-Álvarez M; Cabañas C; Tripodi M; López-Cabrera M; Strippoli R
    J Exp Clin Cancer Res; 2024 Jan; 43(1):27. PubMed ID: 38254102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated fibrosis: a unique mechanism promoting ovarian cancer metastasis and peritoneal dissemination.
    Fujimoto H; Yoshihara M; Rodgers R; Iyoshi S; Mogi K; Miyamoto E; Hayakawa S; Hayashi M; Nomura S; Kitami K; Uno K; Sugiyama M; Koya Y; Yamakita Y; Nawa A; Enomoto A; Ricciardelli C; Kajiyama H
    Cancer Metastasis Rev; 2024 Mar; ():. PubMed ID: 38546906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating integrins with the hallmarks of cancer.
    Haake SM; Rios BL; Pozzi A; Zent R
    Matrix Biol; 2024 Jun; 130():20-35. PubMed ID: 38677444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anchorage Dependence and Cancer Metastasis.
    Lee DK; Oh J; Park HW; Gee HY
    J Korean Med Sci; 2024 May; 39(19):e156. PubMed ID: 38769921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix mediates moruloid-blastuloid morphodynamics in malignant ovarian spheroids.
    Langthasa J; Sarkar P; Narayanan S; Bhagat R; Vadaparty A; Bhat R
    Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34376568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic adaptation in epithelial ovarian cancer metastasis.
    Frederick MI; Nassef MZ; Borrelli MJ; Kuang S; Buensuceso A; More T; Cordes T; O'Donoghue P; Shepherd TG; Hiller K; Heinemann IU
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(7):167312. PubMed ID: 38901649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components.
    Rakina M; Kazakova A; Villert A; Kolomiets L; Larionova I
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide identification and analysis of epithelial-mesenchymal transition-related RNA-binding proteins and alternative splicing in a human breast cancer cell line.
    Mi Y; Dong M; Zuo X; Cao Q; Gu X; Mi H; Xiao F
    Sci Rep; 2024 May; 14(1):11753. PubMed ID: 38783078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterocellular Adhesion in Cancer Invasion and Metastasis: Interactions between Cancer Cells and Cancer-Associated Fibroblasts.
    Yamaguchi H; Miyazaki M
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review.
    Alemzadeh E; Allahqoli L; Mazidimoradi A; Alemzadeh E; Ghasemi F; Salehiniya H; Alkatout I
    Oncol Res; 2024; 32(5):831-847. PubMed ID: 38686048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.
    Gambelli A; Nespolo A; Rampioni Vinciguerra GL; Pivetta E; Pellarin I; Nicoloso MS; Scapin C; Stefanatti L; Segatto I; Favero A; D'Andrea S; Mucignat MT; Bartoletti M; Lucia E; Schiappacassi M; Spessotto P; Canzonieri V; Giorda G; Puglisi F; Vecchione A; Belletti B; Sonego M; Baldassarre G
    EMBO Mol Med; 2024 May; 16(5):1162-1192. PubMed ID: 38658801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment.
    Pampeno C; Opp S; Hurtado A; Meruelo D
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ITGB6 promotes pancreatic fibrosis and aggravates the malignant process of pancreatic cancer via JAK2/STAT3 signaling pathway.
    Zhang Y; Chen Z; Shen Z; Qian D; Wang G; Wang X; Xi S; Wang X
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; ():. PubMed ID: 38418753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer.
    Grither WR; Baker B; Morikis VA; Ilagan MXG; Fuh KC; Longmore GD
    Mol Cancer Res; 2024 May; 22(5):495-507. PubMed ID: 38334461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spheroid architecture strongly enhances miR-221/222 expression and promotes oxidative phosphorylation in an ovarian cancer cell line through a mechanism that includes restriction of miR-9 expression.
    Ward AS; Hall CN; Tree MO; Kohtz DS
    Mol Biol Rep; 2024 Feb; 51(1):275. PubMed ID: 38310615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway.
    Chen PD; Liao YY; Cheng YC; Wu HY; Wu YM; Huang MC
    Oncogenesis; 2023 Oct; 12(1):49. PubMed ID: 37907465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer.
    Harrington BS; Kamdar R; Ning F; Korrapati S; Caminear MW; Hernandez LF; Butcher D; Edmondson EF; Traficante N; Hendley J; ; Gough M; Rogers R; Lourie R; Shetty J; Tran B; Elloumi F; Abdelmaksoud A; Nag ML; Mazan-Mamczarz K; House CD; Hooper JD; Annunziata CM
    J Exp Clin Cancer Res; 2023 Oct; 42(1):270. PubMed ID: 37858159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs Can Influence Ovarian Cancer Progression by Dysregulating Integrin Activity.
    Fasoulakis Z; Psarommati MZ; Papapanagiotou A; Pergialiotis V; Koutras A; Douligeris A; Mortaki A; Mihail A; Theodora M; Stavros S; Karakalpakis D; Papamihail M; Kontomanolis EN; Daskalakis G; Antsaklis P
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer.
    Huang Y; Fan Y; Zhao Z; Zhang X; Tucker K; Staley A; Suo H; Sun W; Shen X; Deng B; Pierce SR; West L; Yin Y; Emanuele MJ; Zhou C; Bae-Jump V
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.